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Abstract 
Aim: to investigate effects of Losartan on expression of connexin 40 and 43 (Cx40 and 
Cx43), in arteries at the early stage of atherosclerosis in a rabbit model. Methods: A total of 
28 male New Zealand white rabbits were divided into following groups: control group, high fat 
diet group, and Losartan group (10 mg/kg/day). Losartan was administrated in food for two 
weeks. Iliac arteries were obtained for immunohistochemistry, transmission electron mi-
croscopy, Western blot, and reverse transcriptase-polymerase chain reaction (RT-PCR). 
Results: Transmission electron microscopy revealed abundant gap junctions between 
neointimal smooth muscle cells (SMCs), which were markedly reduced by treatment. RT-PCR 
and Western blot assay showed that the mRNA and protein expression of Cx40 and Cx43 
were elevated in the neointimal area at the early stage of atherosclerosis. The mRNA and 
protein expression of Cx43 were significantly down-regulated by losartan treatment but 
those of Cx40 were not markedly changed. Conclusion: Cx40 and Cx43 in the neointimal 
SMCs were up-regulated at the early stage of atherosclerosis. Losartan (an angioten-
sin-converting enzyme inhibitor) could reduce neointima proliferation and down-regulate the 
elevated protein expression of Cx43, suggesting the rennin-angiotensin system (RAS) plays an 
important role in the remodeling of gap junction between ventricular myocytes under pa-
thological conditions. 
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Introduction 
Atherosclerosis is a slow and complicated pa-
thological process. Vascular smooth muscle cell 
(VSMC) proliferation is one of the important features 
of atherosclerosis. The gap junction (GJ) and connexin 
(Cx) between cells play crucial roles in the VSMC 
disintegration and proliferation (1). At present, Cx40, 
Cx43 and Cx37 have been identified in the VSMCs (2). 
A variety of in vitro and in vivo experiments have 
proved that GJ may be involved in the injury or dis-
ease induced activation of vessel wall cells. It is indi-
cated that the expression of Cx43 in the smooth mus-
cle cells was markedly elevated at the early stage of 
coronary atherosclerosis (3). Recently, evidence 
showed the expression of Cx40 could also be pro-
foundly increased in the early phase of artery damage.   
Angiotensin II (Ang II) is an effective vasoactive 
peptide, and has been proved to affect the process of 
atherosclerosis. The regulation process mediated 
through G-protein-coupled receptors AT1 and AT2 
(mostly through AT1 receptor) can also be blocked by 
specific receptor antagonist (4). Additionally, a study 
shows that angiotensin-converting enzyme inhibitors 
(ACEI) can inhibit the Ang II induced proliferation 
and migration of smooth muscle cells (5).  
However, little is known about the relationship 
between the up-regulation of Cx43 in early atheros-Int. J. Med. Sci. 2010, 7 
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clerosis and AngII, whether up-regulation of Cx43 can 
be antagonized by AT1 antagonists or whether sup-
pressed smooth muscle cell proliferation and migra-
tion by AT1 antagonists are mediated through de-
creasing VSMC seamless connections. 
The present study aimed to detect the expression 
of Cx40 and Cx43 in the artery at early stage of high 
fat diet induced atherosclerosis and to investigate the 
effects of AT1 antagonist Losartan on the Cx43 and 
Cx40 expression in the VSMCs .  
Methods 
Experimental animal 
New Zealand male purebred albino rabbits 
weighing 2.5-3.3 kg were purchased from the Animal 
Centre of Medical College of Zhejiang University. 
Establishment of the atherosclerosis model  
Twenty eight healthy rabbits were randomly di-
vided into three groups: normal control group (Group 
A, n=7), high fat diet group (Group B, n=7), Losartan 
group (Group C, n=7). Rabbits in the Group A were 
fed with commercially available food; and those in the 
Group B and C were given food containing 1.5% cho-
lesterol (high fat diet) for two weeks. In addition, 
rabbits in the Group C were treated with Losartan 
(10mg/kg/d) in the food for eight weeks. These ani-
mals were given ad libitum access to water. 
Collection of blood vessels  
At the end of the experiment, rabbits were sacri-
ficed. Then the aortas were obtained and washed with 
cold normal saline. The aortas without evident yellow 
plaque were cut into pieces and fixed in 10% para-
formaldehyde. The blood vessels without obvious 
yellow speckle were fragmented into 3 pieces: one 
fixed with 10% neutral buffered formalin, one im-
mersed in 2.5% Glutaral solution, and the third piece 
stored in liquid nitrogen tank after snap frozen at -80 
0C for use.  
Plasma cholesterol level 
Peripheral blood was collected from the ear vein 
under local anesthesia immediately before drug 
treatment/surgical procedures and before sacrificing. 
Plasma cholesterol levels were measured with an au-
toanalyzer (Type 7170, Hitachi Corp., Tokyo, Japan). 
Pathology and immunochemistry 
Iliac arteries were carefully removed and 
post-fixed with 4% paraformaldehyde in phos-
phate-buffered saline (PBS) (pH 7.4) overnight at 4°C. 
Tissue blocks were rinsed for 1 h with PBS and dehy-
drated through a series of increasing concentrations of 
ethanol. After dehydration, these tissues were cleaned 
with chloroform and xylene and then embedded in 
paraffin. Tissues were cut into 6 μm sections. The sec-
tions were deparaffinized, and endogenous perox-
idase was quenched by incubation with 0.3% hydro-
gen peroxide in methanol for 10 min at room temper-
ature. The sections were either stained with hematox-
ylin and eosin or incubated with anti-Cx43 monoc-
lonal antibody (Zymed Laboratories Inc, Carlsbad, 
CA) or anti-Cx40 monoclonal antibody (Alpha Diag-
nostic International Inc, San Antonio, TX) at a dilution 
of 1:1000 in blocking buffer (2% bovine serum albu-
m i n  i n  P B S )  a t  r o o m  t e m p e r a t u r e  o v e r n i g h t .  A f t e r  
washed with PBS, the sections were incubated with 
secondary antibody conjugated to horseradish pe-
roxidase (Histofine simple-stain kit, Nichivei, Japan) 
for 30 min. The sections were visualized with 3, 
3’-diaminobenzidine and hydrogen peroxide, and 
counterstained with hematoxylin. 
Western blot  
Protein extracts were prepared in lysis buffer 
and then repeatedly aspirated (20 times) through a 
23-gauge needle followed by centrifugation at 4°C for 
30 min at 10,000 g. The supernatant was submitted for 
protein quantification. Samples (20 μg of total pro-
teins for Cx40 and 4 μg for Cx43) were added with gel 
loading buffer, and aliquots were loaded onto a 12.5% 
sodium dodecyl sulfate-polyacrylamide gel. After 
separation, proteins were transferred to nitrocellulose 
membranes which were then blocked for 30 min in 
PBS containing 5% nonfat milk and 0.1% Tween. The 
membranes were subsequently incubated overnight 
with either the anti-Cx43 monoclonal antibody 
(1:1,000, Zymed Laboratories Inc.) or anti-Cx40 mo-
noclonal antibody (1:1,000, Alpha Diagnostic Interna-
tional Inc.) or with anti-actin antibody (1:500, Phar-
Mingen, San Jose, CA). After washing in PBS con-
taining 0.1% Tween, membranes were probed for 1 h 
with the corresponding horseradish peroxidase- con-
jugated secondary antibodies (anti-rabbit: 1:1,000, 
anti-mouse: 1:500; Chemicon, Temecula, CA). The 
time of incubation in ECL detection reagents and ex-
posure to Hyperfilm (Amersham-Pharmacia, Buck-
inghamshire, UK) were identical for all experimental 
conditions. The intensity of the bands was determined 
by laser scanning the films followed by quantitative 
densitometric analysis using Kodak Digital Science 
1D 2.0 Image software.  
RT-PCR 
Total RNA was extracted using Trizol (Life 
Technologies, Gaithersburg, MD). Then, 2.5 μg of total 
RNA were reverse transcribed into cDNA in 50 μl of 
reaction mixtures using 200 U of recombinant M-MLV Int. J. Med. Sci. 2010, 7 
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reverse transcriptase (Superscript II, GIBCO-BRL) and 
oligo dT15 as primers. The RT was carried out for 60 
min at 42°C followed by an inactivation step at 94°C 
for 10 min. The RT products were stored at -80°C. The 
amount of RNA was determined by measuring the 
absorbance at 260 nm. Oligonucleotide primers were 
as follows: a) glyceraldehyde phosphated dehydro-
genase (GAPDH): forward: 5’-GCGCCTGGTC 
ACCAGGGCTGCTT-3’, reverse: 5’-TGCCGAAGTG 
GTCGTGGATGACCT-3’; b) Cx40-1: forward: 
5’-ATGCACACTGTGCGCATGCAGGA-3’, reverse: 
5’-CAGGTGGTAGAGTTCAGCCAG-3’; c) Cx43-1: 
forward:  5’-CATCTTCATGCTGGTGGTGT-3’, re-
verse: 5’-TAGTTCGCCCAGTTTTGCTC-3’. Comput-
er-assisted primer selection (Gene Runner, Hastings 
Software) was conducted to determine the primers for 
Cx43. The anticipated size of amplification products 
was 399 bp for Cx40, 283 bp for Cx43, and 465 bp for 
GAPDH. 
Expression of Cx40 and Cx43 was determined by 
semiquantitative PCR using GAPDH as an internal 
standard. The samples were subjected to 28 (Cx40) or 
30 (Cx43) cycles of amplification as follows: the sam-
ples were initially heated to 94°C for 5 min to ensure 
complete denaturation of DNA (45 sec for subsequent 
cycles) followed by 45 sec at 57°C (Cx40) or 51°C 
(Cx43) to anneal primers, and then 1 min at 72°C for 
extension of annealed primer. The PCR reaction was 
concluded by a 10-min elongation phase, again at 
72°C. The PCR products (10 μl) were visualized on 2% 
agarose gel. Images were captured using a solid-state 
black-and-white video camera (Cohu Electronic, Ir-
vine, CA), and the intensity of the bands was deter-
mined using Kodak Digital Science 1D 2.0 imaging 
software. 
Statistical Analysis 
Data are presented as mean ± SD. Data of mul-
tiple groups were analyzed by one-way analysis of 
variance. Means between two groups were compared 
with a two-tailed Student t test after an F test for ho-
mogeneity of variances. If the data failed to meet the 
requirements for the parametric t  test, a 
Mann-Whitney U test was performed. A value of P<0 
.05 was considered statistically significant.  
Results 
Changes in the body weight and plasma choles-
terol level  
The body weight and plasma cholesterol level 
immediately before experiment and sacrificing were 
shown in the Table 1. There is no significant difference 
in the body weight and total cholesterol level at the 
baseline between different groups (P>0.05); Eight 
weeks later, plasma cholesterol in the normal group 
was significantly lower than the other two groups 
(P<0.01) but no significant difference was observed 
between the Losartan group and the high fat diet 
group (P>0.05). The body weight at the end of expe-
riment was did not change significantly compared 
with that at baseline (P>0.05). Furthermore, there was 
no significant difference in the body weight among 
the three groups.  
Table 1. Body weight and plasma cholesterol levels before 
and after treatment 
   Group  n  Plasma cholesterol 
(mmol/L) 
Body weight (kg) 
Baseline  8 weeks  Baseline  8 weeks 
Normal 
group 
7  1.35±0.18  1.37±0.12 2.87±0.21  3.01±0.24 
High fat 
diet group 
7  1.34±0.10  1.68±0.13** 2.81±0.20  3.16±0.20 
Losartan 
group 
7  1.36±0.18  1.61±0.15** 2.82±0.20  3.07±0.16 
Data were expressed as mean±SD.  
**P＜0.01 vs Normal group; Losartan group vs high fat diet group P
＞0.05 
Morphologic changes  
The internal wall of vessels was slick in the 
normal group, while lumens were smaller in the high 
fat diet group than in the normal group. Vessel wall is 
in the condition of rugosity and the yellow athero-
matous plaques were found in the lumens of high fat 
diet group. However, the vessel wall was expanded to 
different extents and little yellow atheromatous pla-
ques were observed in the Losartan group. 
Sections were stained with HE and observed 
under a light microscope. The vessel wall was round 
and homogeneous in the thickness. The inner and 
outer internal elastic laminas were clear and intact in 
the normal group. The nucleus of endothelial cells 
was blue and arranged regularly, and the nucleus of 
smooth muscle cells in the tunica media was shut-
tle-shaped and no smooth muscle cells appeared to 
slip into the subcortex. 
Intima was increased sharply accompanied by a 
large amount of foam cells in the high fat diet group. 
Smooth muscle cells in the tunica media were hyper-
plasia and arranged in chaos. Parts of smooth muscle 
cells arranged in length with the tendency of growing 
to the intima.  
The wall of arteries was basically homogeneous 
in thickness in the Losartan group, only slight fresh 
endomembrane was seen under the endomembrane, 
and a small amount of macrophages and inflamma-
tory cells were noted between the smooth muscle cells 
and the internal elastic lamina was intact (Fig.1).  Int. J. Med. Sci. 2010, 7 
 
http://www.medsci.org 
85
Immunocytochemistry 
The relatively low expression of Cx43 and Cx40 
in VSMCs and endothelial cells was observed in the 
normal group. However, the expression of Cx43 and 
Cx40 in the intima and tunica media of the high fat 
diet group was markedly increased when compared 
with normal group. In the Losartan group, the ex-
pression of Cx40 in the intima did not profoundly 
change compared with the high fat diet group (Fig. 2). 
Transmission electron microscopy  
Transmission electron microscopy showed that 
there were many large-volume gap junction struc-
tures between proliferating smooth muscle cells, but 
few small-volume gap junction structures were ob-
served between normal smooth muscle cells (Fig. 3). 
Western blot assay  
To optimize the protocol, different amounts of 
total proteins were tested for Western blot analysis. 
The amount of the protein was increased sequentially 
from 0.5 μg, 1.0 μg, 1.5 μg, 2.0 μg, 3.0 μg, 4.0 μg, 5.0 μg, 
6.0 μg, 8.0 μg, 10.0 μg, 15.0 μg, 17.5 μg, 20.0 μg, 25.0 μg 
and 30.0 μg. The optimal concentration was 4 μg for 
Cx43 and 20 μg for Cx40, respectively. The relative 
optical density of the Cx43 and Cx40 of different 
groups was shown in Table 2. 
Table 2. The relative optical density of the Cx43 and Cx40 
of different groups 
  Normal group  High fat diet group Losartan  group 
Cx43 (n=7)  0.63±0.10  1.39±0.08** 0.96±0.09*## 
Cx40 (n=7)  0.71±0.13  1.17±0.12** 1.07±0.14 
**P<0.01 vs normal group, ##P<0.01 vs high fat diet group. 
 
As shown in Table 2, the expression of Cx43 and 
Cx40 in the high-fat diet group is significantly in-
creased when compared with the normal group 
(P<0.01), and the expression of Cx43 in the Losartan 
group was higher than that in the normal group 
(P<0.01), but significantly lower than that in the 
high-fat diet group (P<0.05). There was no significant 
difference in the expression of Cx40 between losartan 
group and high-fat diet group (P>0.05). 
Figure 4 and 5 independently showed the pro-
tein expression of Cx43 and Cx40 in the iliac arteries 
of different groups.  
 
 
 
 
Figure 1. Hematoxylin/eosin staining of the iliac arteries in the normal group (panel A), high fat diet group (panel B), and 
high fat diet plus losartan group (panel C). In panel A, the elastic lamina was clear and intact; endothelia and smooth muscle 
cells (arrow) arranged regularly. In panel B, the elastic lamina was incomplete and neointima was exposed. Numerous 
smooth muscle cells near the internal elastic lamina arranged irregularly and extended to the intima (arrow). After treatment 
with losartan as shown in panel C, less neointima was markedly exposed. Int. J. Med. Sci. 2010, 7 
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Figure  2 Immuno-
histochemistry for 
connexin 40 (Cx40) 
and connexin 43 
(Cx43) in the rabbit 
iliac arteries. Cx40 
expression was shown 
in panel A, B, and C and 
Cx43 expression in 
panel D, E, and F. Panel 
A: Cx40 staining 
(brown spots, arrow) 
between the smooth 
muscle cells in the tu-
nica media of iliac arte-
ries from the normal 
group. Panel B: Cx40 
staining was distributed 
in both the tunica me-
dia and neointima with 
more prominent stain-
ing in the latter. Panel 
C: After losartan   
treatment, Cx40 stain-
ing was markedly re-
duced in the neointima 
of arteries. The distri-
bution of Cx43 was 
similar to that of Cx40. 
 
Figure 3 Thin-section electron micrographs indicated gap junctions between smooth muscle cells in the rabbit iliac arteries 
of the normal group (panel A), high fat diet group (panel B), and high fat diet plus losartan group (panel C). In panel B, 
neointimal smooth muscle cells showed abundant and large gap junction when compared with normal group and losartan 
treated group. Bar=0.2 μm  for panels A, B, C and D, × 65,000. Int. J. Med. Sci. 2010, 7 
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Figure  4: Protein expression of Cx43 (panel A) and Cx40 (panel B) in the rabbit iliac arteries of different groups. Top 
panels independently represented the expression of Cx43 and Cx40 from different groups and bottom panels are Actin. 1) 
normal control (n =7); 2) high fat diet group (n =7); 3) high fat diet + losartan (n = 7). *P<0.05, **P<0.01 vs normal group,
 
##P<0.01 vs high fat diet group. 
 
 
 
Figure  5: mRNA expression of Cx40 (panel A) and Cx43 (panel B) in the rabbit iliac arteries of different groups by 
RT-PCR. Top panels represented mRNA expression of Cx40 and Cx43 from each of the groups and bottom panels are 
Actin. 1) normal control (n =7); 2) high fat diet group (n =7); 3) high fat diet group + losartan (n =7). *P <0.05, **P<0.01 vs 
normal group,
 ##P<0.01 vs high fat diet group. 
 
mRNA expression of Cx43 and Cx40 by RT-PCR 
As shown in Figure 5, after 2% agarose gel elec-
trophoresis, the bands were visualized and length of 
amplified products of Cx43, Cx40 and GAPDH was 
about 283 bp, 399bp and 465bp, respectively, which 
were within the anticipated size. 
The relative optical density of the amplified 
products of Cx43 and Cx40 from different groups is 
shown in Table 3.  
As shown in Table 3, the mRNA expression of 
Cx43 and Cx40 in the high-fat diet group was signifi-Int. J. Med. Sci. 2010, 7 
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cantly increased when compared with the normal 
group (P <0.01). The mRNA expression of Cx43 in the 
Losartan group was higher than in the normal group 
(P<0.05), but significantly lower than in the high-fat 
diet group (P<0.01). No significant difference in the 
mRNA expression of Cx40 was observed between the 
Losartan group, losartan group and high-fat diet 
group (P>0.05).    
 
Table 3. The relative optical density of the amplified 
products of Cx43 and Cx40 from different groups  
  Normal group High fat diet group Losartan  group 
Cx43 (n=7) 0.46±0.12 1.02±0.13** 0.71±0.14 ## 
Cx40 (n=7) 0.28±0.14 0.82±0.12** 0.74±0.12** 
**P<0.01 vs normal group, ##P<0.01 vs high fat diet group. 
 
Discussion 
This study shows that many large gap junction 
structures exist between the proliferating vascular 
smooth muscle cells in the early atherosclerosis of 
rabbits with elevated expression of Cx43 and Cx40 
mRNAs and proteins. Losartan, an AT1 antagonist, 
may not reduce the level of blood lipids induced by 
high-fat diet, but it may inhibit the expression of Cx43 
mRNA and protein, suppress proliferation of vascular 
smooth muscle cells. These results are consistent with 
a hypothesis that the anti-atherosclerosis role of AT1 
receptor inhibitors may be independent on lipid level, 
but may be partly dependent on the inhibition of gap 
junctional communication and thus the proliferation 
of vascular smooth muscle cells. 
Intima of artery has mutual communication be-
tween cells and between cells and their environment. 
These cells in the vessel walls are involved in the de-
velopment of atherosclerosis (6). In the normal vessel 
walls, GJ plays a very important role in regulating 
seamless connection (7). 
The transition and hyperplasia of VSMCs (from 
contraction transformation to the secretary) is a key 
step in the development of atherosclerosis (4). During 
this process, VSMC originally came from vascular 
media must be released from the riveting of gap junc-
tional connection. Cx43 was up-regulated when the 
smooth muscle cells changed from contraction type to 
the conversion type in vitro (8). 
Cx43 is required for the formation of the athe-
rosclerotic plaque. Previous study demonstrated that 
rats lack of Cx43 expression showed 50% lower rate of 
attack with atherosclerotic plaque compared with 
normal rats (9). Our study demonstrates an associa-
tion of the formation of atherosclerosis and the ex-
pression and function of gap junction. White blood 
cells (WBC) can be induced by chemokines through 
gap junction formed between WBC and endothelium 
and resulted in the formation of atherosclerosis (9). 
Javid et al. also found that in the early stage of athe-
rosclerosis, the number of Cx43 gap junction plaques 
increased and the diameter of gap junction became 
smaller in during endometrial thickening. During the 
progression of the disease, the diameter of gap junc-
tion plaques increased and the number of gap junc-
tion plaques decreased (10). Ang II, a strong vasocon-
strictor substance, stimulates mitosis that results in 
the proliferation of VSMCs and fibroblasts and colla-
gen deposition. Ang II is also involved in the initiation 
and development of atherosclerosis (11). One study 
found that the activity of ACE, the number of Ang II, 
and angiotensin receptor 1 were significantly in-
creased in coronary atherosclerosis plaques (12). Ang 
II targets to vascular endothelial cells, monocytes, 
macrophages, and smooth muscle cells, promotes 
angiogenesis and lipid metabolism, and participates 
in the pathological process (11). Another study 
showed that Ang II up-regulated the expression of 
Cx43 in WB rat liver cells, which resulted in changes 
of cell metabolism conditions and second messengers 
(13). Cx43 expression can be induced by treating 
neonatal rat ventricular muscle cells with Ang II for 24 
hours; the reaction can be inhibited by AT1 receptor 
antagonist Losartan, suggesting that Ang II functions 
through the AT1 (14). 
The study also confirmed that Cx40, another 
important protein formed gap junction, is expressed 
in the abdominal aortic smooth muscle cells in rabbits 
and up-regulated in the early proliferation of athe-
rosclerosis. The study showed that Cx43 and Cx40 
protein can not form a heterogeneous gap junction. It 
is also not known about the role they play in cell 
growth and differentiation (15). 
This study showed that Cx40 mRNA expression 
can not be changed by Losartan. Polontchouk et al. 
observed that, after the neonatal rat heart cells were 
treated with Ang II after 24 h, expression of Cx43, but 
not Cx40, and GJ communication increased (16). 
These results suggest that the expression of Cx40 
mRNA induced by high-fat diet is independent of the 
role of Ang II.  
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